The Zhitong Finance App learned that on June 7, the CDE official website showed that MSD (MRK.US)'s pabolizumab injection (subcutaneous injection, that is, MK-3475A) was declared for sale in China.

Zhitongcaijing · 06/09 13:09
The Zhitong Finance App learned that on June 7, the CDE official website showed that MSD (MRK.US)'s pabolizumab injection (subcutaneous injection, that is, MK-3475A) was declared for sale in China.